Neuronetics, Inc. – NASDAQ:STIM

Neuronetics stock price today

$3.4
+1.92
+129.73%
Financial Health
0
1
2
3
4
5
6
7
8
9

Neuronetics stock price monthly change

-20.86%
month

Neuronetics stock price quarterly change

-20.86%
quarter

Neuronetics stock price yearly change

-45.59%
year

Neuronetics key metrics

Market Cap
44.76M
Enterprise value
36.60M
P/E
-1.98
EV/Sales
0.56
EV/EBITDA
-1.17
Price/Sales
1.03
Price/Book
1.17
PEG ratio
0.15
EPS
-0.96
Revenue
73.22M
EBITDA
-21.2M
Income
-27.54M
Revenue Q/Q
12.07%
Revenue Y/Y
10.00%
Profit margin
-56.99%
Oper. margin
-53.85%
Gross margin
76.26%
EBIT margin
-53.85%
EBITDA margin
-28.95%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Neuronetics stock price history

Neuronetics stock forecast

Neuronetics financial statements

Neuronetics, Inc. (NASDAQ:STIM): Profit margin
Jun 2023 17.61M -4.90M -27.83%
Sep 2023 17.88M -9.39M -52.51%
Dec 2023 20.31M -5.37M -26.47%
Mar 2024 17.41M -7.87M -45.2%
Neuronetics, Inc. (NASDAQ:STIM): Analyst Estimates
Mar 2024 17.41M -7.87M -45.2%
Sep 2025 22.38M -4.55M -20.33%
Oct 2025 22.15M -4.92M -22.21%
Dec 2025 24.64M -3.55M -14.42%
  • Analysts Price target

  • Financials & Ratios estimates

Neuronetics, Inc. (NASDAQ:STIM): Debt to assets
Jun 2023 100392000 54.91M 54.7%
Sep 2023 92988000 55.04M 59.2%
Dec 2023 115831000 81.64M 70.48%
Mar 2024 103811000 76.15M 73.36%
Neuronetics, Inc. (NASDAQ:STIM): Cash Flow
Jun 2023 -15.03M 5.55M -62K
Sep 2023 -10.12M 66K 0
Dec 2023 2.13M -563K 22.26M
Mar 2024 -12.01M 68K 0

Neuronetics alternative data

Neuronetics, Inc. (NASDAQ:STIM): Employee count
Aug 2023 200
Sep 2023 209
Oct 2023 209
Nov 2023 209
Dec 2023 211
Jan 2024 211
Feb 2024 211
Mar 2024 203
Apr 2024 203
May 2024 203
Jun 2024 202
Jul 2024 202

Neuronetics other data

77.39% +1.40%
of STIM is owned by hedge funds
19.71M -267.32K
shares is hold by hedge funds

Neuronetics, Inc. (NASDAQ:STIM): Insider trades (number of shares)
Period Buy Sel
Dec 2023 0 34991
Jan 2024 0 19529
Feb 2024 0 181040
Jun 2024 50000 0
Jul 2024 0 47924
Aug 2024 184171 0
Sep 2024 125000 0
Oct 2024 0 2909
Transaction Date Insider Security Shares Price per share Total value Source
Sale
FURLONG STEPHEN officer: EVP, CFO and Treasurer
Common Stock 1,368 $0.82 $1,122
Sale
MACAN WILLIAM ANDREW officer: EVP, GC, CCO and CS
Common Stock 1,541 $0.82 $1,264
Purchase
CASCELLA ROBERT director
Common Stock 100,000 $0.75 $75,000
Purchase
MUIR GLENN P director
Common Stock 25,000 $0.8 $20,000
Purchase
MUIR GLENN P director
Common Stock 12,224 $0.85 $10,390
Purchase
MUIR GLENN P director
Common Stock 12,776 $0.85 $10,860
Purchase
MUIR GLENN P director
Common Stock 25,000 $1 $25,000
Purchase
CASCELLA ROBERT director
Common Stock 4,000 $1.14 $4,560
Purchase
CASCELLA ROBERT director
Common Stock 35,000 $1.06 $37,100
Purchase
CASCELLA ROBERT director
Common Stock 35,000 $0.88 $30,800
Patent
Application
Filling date: 28 Feb 2022 Issue date: 9 Jun 2022
Application
Filling date: 14 Oct 2021 Issue date: 3 Feb 2022
Application
Filling date: 16 Apr 2021 Issue date: 29 Jul 2021
Application
Filling date: 22 Mar 2021 Issue date: 8 Jul 2021
Grant
Filling date: 20 Feb 2018 Issue date: 11 May 2021
Grant
Filling date: 10 Dec 2018 Issue date: 20 Apr 2021
Application
Filling date: 9 Apr 2020 Issue date: 6 Aug 2020
Application
Filling date: 10 Mar 2020 Issue date: 2 Jul 2020
Grant
Filling date: 8 Mar 2019 Issue date: 28 Apr 2020
Grant
Filling date: 21 Feb 2018 Issue date: 14 Apr 2020
Insider Compensation
Mr. Keith J. Sullivan (1958) Pres, Chief Executive Officer & Director $832,670
Mr. Stephen J. Furlong M.S. (1965) Senior Vice President, Chief Financial Officer & Treasurer
$701,670
Mr. W. Andrew Macan (1973) Senior Vice President, Gen. Counsel, Chief Compliance Officer, Sec. & Member of Office of the Pres
$692,610
Wednesday, 18 December 2024
globenewswire.com
Monday, 16 December 2024
globenewswire.com
Tuesday, 10 December 2024
globenewswire.com
Wednesday, 20 November 2024
globenewswire.com
Tuesday, 12 November 2024
seekingalpha.com
globenewswire.com
globenewswire.com
zacks.com
globenewswire.com
Tuesday, 29 October 2024
globenewswire.com
Monday, 14 October 2024
globenewswire.com
Friday, 4 October 2024
prnewswire.com
Wednesday, 25 September 2024
globenewswire.com
Monday, 23 September 2024
zacks.com
Thursday, 19 September 2024
globenewswire.com
Monday, 16 September 2024
globenewswire.com
Tuesday, 3 September 2024
globenewswire.com
Tuesday, 13 August 2024
zacks.com
zacks.com
zacks.com
Monday, 12 August 2024
seekingalpha.com
benzinga.com
zacks.com
globenewswire.com
globenewswire.com
Monday, 5 August 2024
globenewswire.com
Thursday, 1 August 2024
globenewswire.com
Tuesday, 30 July 2024
globenewswire.com
Monday, 29 July 2024
globenewswire.com
Monday, 22 July 2024
globenewswire.com
  • What's the price of Neuronetics stock today?

    One share of Neuronetics stock can currently be purchased for approximately $3.4.

  • When is Neuronetics's next earnings date?

    Unfortunately, Neuronetics's (STIM) next earnings date is currently unknown.

  • Does Neuronetics pay dividends?

    No, Neuronetics does not pay dividends.

  • How much money does Neuronetics make?

    Neuronetics has a market capitalization of 44.76M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 9.42% to 71.35M US dollars.

  • What is Neuronetics's stock symbol?

    Neuronetics, Inc. is traded on the NASDAQ under the ticker symbol "STIM".

  • What is Neuronetics's primary industry?

    Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.

  • How do i buy shares of Neuronetics?

    Shares of Neuronetics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Neuronetics's key executives?

    Neuronetics's management team includes the following people:

    • Mr. Keith J. Sullivan Pres, Chief Executive Officer & Director(age: 67, pay: $832,670)
    • Mr. Stephen J. Furlong M.S. Senior Vice President, Chief Financial Officer & Treasurer(age: 60, pay: $701,670)
    • Mr. W. Andrew Macan Senior Vice President, Gen. Counsel, Chief Compliance Officer, Sec. & Member of Office of the Pres(age: 52, pay: $692,610)
  • How many employees does Neuronetics have?

    As Jul 2024, Neuronetics employs 202 workers, which is 0% less then previous quarter.

  • When Neuronetics went public?

    Neuronetics, Inc. is publicly traded company for more then 7 years since IPO on 28 Jun 2018.

  • What is Neuronetics's official website?

    The official website for Neuronetics is neurostar.com.

  • Where are Neuronetics's headquarters?

    Neuronetics is headquartered at 3222 Phoenixville Pike, Malvern, PA.

  • How can i contact Neuronetics?

    Neuronetics's mailing address is 3222 Phoenixville Pike, Malvern, PA and company can be reached via phone at +61 6404202.

Neuronetics company profile:

Neuronetics, Inc.

neurostar.com
Exchange:

NASDAQ

Full time employees:

203

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

3222 Phoenixville Pike
Malvern, PA 19355

CIK: 0001227636
ISIN: US64131A1051
CUSIP: 64131A105